SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Global Retirement Partners LLC

Global Retirement Partners LLC trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,902 shares of the exchange traded fund’s stock after selling 842 shares during the quarter. Global Retirement Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $441,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. FMR LLC boosted its position in shares of SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after buying an additional 830 shares during the period. Ameritas Advisory Services LLC boosted its position in SPDR S&P Biotech ETF by 11.9% during the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after acquiring an additional 1,137 shares during the period. Beaton Management Co. Inc. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter worth $212,000. Van ECK Associates Corp acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at $1,497,000. Finally, Hollow Brook Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 4.9% during the third quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock valued at $2,141,000 after purchasing an additional 1,003 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 1.1 %

Shares of XBI opened at $91.70 on Monday. The firm has a market capitalization of $6.99 billion, a PE ratio of 11.47 and a beta of 1.11. The firm has a 50-day moving average price of $91.36 and a 200 day moving average price of $96.00. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.